Search Results - "BEUERS, U"

Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience by Rassam, F., Roos, E., van Lienden, K. P., van Hooft, J. E., Klümpen, H. J., van Tienhoven, G., Bennink, R. J., Engelbrecht, M. R., Schoorlemmer, A., Beuers, U. H. W., Verheij, J., Besselink, M. G., Busch, O. R., van Gulik, T. M.

“…Aim Perihilar cholangiocarcinoma (PHC) is a challenging disease and requires aggressive surgical treatment in order to achieve curation. The assessment and…”
Get full text

Pharmacokinetics of ceftriaxone, gentamicin, meropenem and vancomycin in liver cirrhosis: a systematic review by Comce, M H, Weersink, R A, Beuers, U, van Hest, R M, Lantinga, M A

“…Patients with liver cirrhosis are prone to develop severe bacterial infections. Pharmacokinetics (PK) of antibiotics in cirrhosis are potentially affected by…”
Get full text

The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial) by van Rijswijk, A, van Olst, N, Meijnikman, A. S, Acherman, Y. I. Z, Bruin, S. C, van de Laar, A. W, van Olden, C. C, Aydin, O, Borger, H, Beuers, U. H. W, Herrema, H, Verheij, J, Apers, J. A, Bäckhed, F, Gerdes, V. E. A, Nieuwdorp, M, de Brauw, L. M

“…Abstract Background Metabolic surgery induces rapid remission of type 2 diabetes mellitus (T2DM). There is a paucity of high level evidence comparing the…”
Get full text

HLA-DRB103:01 and HLA-DRB104:01 modify the presentation and outcome in autoimmune hepatitis type-1 by van Gerven, N M F, de Boer, Y S, Zwiers, A, Verwer, B J, Drenth, J P H, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M J, Vrolijk, J M, Coenraad, M J, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L, Bouma, G

“…The classical human leukocyte antigen (HLA)-DRB1*03:01 and HLA-DRB1*04:01 alleles are established autoimmune hepatitis (AIH) risk alleles. To study the…”
Get full text

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes by Baven‐Pronk, A. M. C., Coenraad, M. J., van Buuren, H. R., de Man, R. A., van Erpecum, K. J., Lamers, M. M. H., Drenth, J. P. H., van den Berg, A. P., Beuers, U. H., den Ouden, J., Koek, G. H., van Nieuwkerk, C. M. J., Bouma, G., Brouwer, J. T., van Hoek, B.

“…Aliment Pharmacol Ther 2011; 34: 335–343 Summary Background  Treatment failure occurs in 20% of autoimmune hepatitis patients on prednisolone and azathioprine…”
Get full text

Prognostic and mechanistic potential of progesterone sulfates in intrahepatic cholestasis of pregnancy and pruritus gravidarum by Abu‐Hayyeh, Shadi, Ovadia, Caroline, Lieu, TinaMarie, Jensen, Dane D., Chambers, Jenny, Dixon, Peter H., Lövgren‐Sandblom, Anita, Bolier, Ruth, Tolenaars, Dagmar, Kremer, Andreas E., Syngelaki, Argyro, Noori, Muna, Williams, David, Marin, Jose J.G., Monte, Maria J., Nicolaides, Kypros H., Beuers, Ulrich, Oude‐Elferink, Ronald, Seed, Paul T., Chappell, Lucy, Marschall, Hanns‐Ulrich, Bunnett, Nigel W., Williamson, Catherine

“…A challenge in obstetrics is to distinguish pathological symptoms from those associated with normal changes of pregnancy, typified by the need to differentiate…”
Get full text

Doppler follow-up after TIPS placement is not routinely indicated. A 16-years single centre experience by de Wit, K, van Delden, O M, Beuers, U, Takkenberg, R B

“…Transjugular intrahepatic portosystemic shunt (TIPS) is an effective intervention to treat complications of portal hypertension. Since the introduction of…”
Get full text

Prevention of hepatic encephalopathy by administration of rifaximin and lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt (TIPS): a multicentre randomised, double blind, placebo controlled trial (PEARL trial) by de Wit, K, Schaapman, J J, Nevens, F, Verbeek, J, Coenen, S, Cuperus, F J C, Kramer, M, Tjwa, E T T L, Mostafavi, N, Dijkgraaf, M G W, van Delden, O M, Beuers, U H W, Coenraad, M J, Takkenberg, R B

“…IntroductionCirrhotic patients with portal hypertension can suffer from variceal bleeding or refractory ascites and can benefit from a transjugular…”
Get full text

Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC alpha-/PKA-dependent mechanism in rat liver by Wimmer, R, Hohenester, S, Pusl, T, Denk, G U, Rust, C, Beuers, U

“…Ursodeoxycholic acid (UDCA) exerts anticholestatic effects in part by protein kinase C (PKC)-dependent mechanisms. Its taurine conjugate, TUDCA, is a cPKC…”
Get more information

A 22-year-old mother with severe pruritus and increasing jaundice two weeks after starting hormonal contraception by Guth, C, Beuers, U, Beckh, K

“…Intermittent cholestatic liver disease may indicate an inherited deficiency of bile salt transport proteins. Episodes of cholestasis may start during pregnancy…”
Get more information

IgG4 and IgG1 autoantibodies against Annexin A11 in IgG4-related disease of the biliary tract and pancreas by Hubers, L, Vos, H, Schuurman, A, Elferink, R.O, Burgering, B, van de Graaf, S, Beuers, U

Get full text

Ursodeoxycholic acid — adverse effects and drug interactions by Hempfling, W., Dilger, K., Beuers, U.

“…Summary Background : Ursodeoxycholic acid is increasingly being used for the treatment of chronic cholestatic liver diseases. It appears to be generally well…”
Get full text

Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment by Overbeek, Kasper A., Poulsen, J., Lanzillotta, M., Vinge-Holmquist, O., Macinga, P., Demirci, A., Sindhunata, D., Backhus, J., Algül, H., Buijs, J., Levy, P., Kiriukova, M., Goni, E., Hollenbach, M., Miksch, R., Kunovský, L., Vujasinovic, M., Nikolic, S., Dickerson, L., Hirth, M., Neurath, M., Zumblick, M., Vila, J., Jalal, M., Beyer, G., Frost, F., Carrara, S., Kala, Z., Jabandžiev, P., Sisman, G., Akyuz, F., Capurso, G., Falconi, M., Arlt, A., Vleggaar, F., Barresi, L., Greenhalf, B., Czakó, L., Hegyi, P., Hopper, A., Nayar, M., Gress, T., Vitali, F., Schneider, A., Halloran, C., Trna, J., Okhlobystin, A., Dagna, L., Cahen, D., Bordin, D., Rebours, V., Mayerle, J., Kahraman, A., Rasch, S., Culver, E., Kleger, A., Martínez-Moneo, E., Røkke, O., Hucl, T., Olesen, S., Bruno, M., Della-Torre, E., Beuers, U., Löhr, J., Rosendahl, J.

Get full text

What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree by Maillette de Buy Wenniger, L, Rauws, E A, Beuers, U

“…Autoimmune pancreatitis (AIP) and IgG4-associated cholangitis (IAC) are the recently recognized pancreatobiliary manifestations of IgG4-associated systemic…”
Get more information

Ursodeoxycholic Acid in Advanced Polycystic Liver Disease: A Multicenter Randomized Controlled Phase 2 Trial (Cursor) by D’Agnolo, H.M.A, Kievit, W, Takkenberg, B, Riano, I, Bujanda, L, Neijenhuis, M, Brunenberg, E, Beuers, U, Banales, J, Drenth, J

Get full text

Pruritus and Serum Autotaxin in Patients with Primary Biliary Cirrhosis Participating in the Poise Trial by Kremer, A.E, Bolier, A.R, Malecha, E.S, Beuers, U, Erickson, M, Hooshmand-Rad, R, Shapiro, D

Get full text

Mitigation of Pruritus during Obeticholic Acid Treatment in Patients with Primary Biliary Cirrhosis: Strategies and Successes by Mayo, M.J, Kremer, A, Beuers, U, Marmon, T, Hooshmand-Rad, R, Pencek, R, Shapiro, D

Get full text

Combined Activity of NTCP and OATPS Governs Hepatic Uptake of Conjugated Bile Acids in Vivo by Slijepcevic, D, Tolenaars, D, de Waart, D.R, Beuers, U, Elferink, R.O, Schinkel, A, Van De Graaf, S

Get full text

Systematic review: ursodeoxycholic acid: adverse effects and drug interactions by HFMPFLING, W, DILGER, K, BEUERS, U

“…Ursodeoxycholic acid is increasingly being used for the treatment of chronic cholestatic liver diseases. It appears to be generally well tolerated, but a…”
Get full text

Chronic hepatitis E after solid organ transplantation by DE NIET, A, ZAAIJER, H. L, TEN BERGE, I, WEEGINK, C. J, REESINK, H. W, BEUERS, U

“…Large outbreaks of acute hepatitis E, caused by hepatitis E virus (HEV) genotypes 1 and 2, are known from developing countries with suboptimal sanitation…”
Get full text